Noreen Henig

Director at Avidity Biosciences · 2 reported transactions in 2 companies · latest report Feb 27, 2026

Their trades


Avidity BiosciencesRNAM	Returned to company — · 6,692 shares	Feb 27, 2026
Atrium TherapeuticsRNA	Share award — · 6,692 shares	Jun 10, 2025

Feb 27, 2026 · RNAM

6,692

Jun 10, 2025 · RNA

6,692

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.

Director at Avidity Biosciences · 2 reported transactions in 2 companies · latest report Feb 27, 2026


Avidity BiosciencesRNAM	Returned to company — · 6,692 shares	Feb 27, 2026
Atrium TherapeuticsRNA	Share award — · 6,692 shares	Jun 10, 2025

Feb 27, 2026 · RNAM

6,692

Jun 10, 2025 · RNA

6,692

2 transactionsPro adds every trade with how it did, their holdings and the money-flow chartPro is $29 a month

Built from their public trade reports and market prices: past moves, not predictions or advice.